Evaluation of the Coris Legionella V-Test. In comparison with the Trinity Biotech EIA Legionella Urinary Antigen test

Size: px
Start display at page:

Download "Evaluation of the Coris Legionella V-Test. In comparison with the Trinity Biotech EIA Legionella Urinary Antigen test"

Transcription

1 Evaluation of the Coris Legionella V-Test In comparison with the Trinity Biotech EIA Legionella Urinary Antigen test 06/September/2010 Coris BioConcept

2 Report of Clinical Performance Study of Legionella V-Test Coris BioConcept test in comparison with EIA Legionella Urinary Antigen test Trinity Biotech Truthful and Accurate Statement I, Jose Domínguez certify that, in my capacity as Senior Researcher, I believe to the best of my knowledge, that all data and information submitted in the above referenced Report of Clinical Performance Study are truthful and accurate and that no material fact has been omitted. These data belong to Coris BioConcept, therefore they can be used for any commercial purpose. Signature: Date: 06/ September/ 2010

3 Report of Clinical Performance Study of Legionella V-Test Coris BioConcept test in comparison with EIA Legionella Urinary Antigen test Trinity Biotech Place where test was performed: Servei de Microbiologia. Hospital Universitari Germans Trias I Pujol. Carretera del Canyet s/n Badalona. Barcelona. Spain Lead Investigator, Responsible Person of the investigation: Jose Domínguez Collaborator Investigator: Silvia Blanco Period of Testing: Two months after receiving the kits. Product evaluated: Legionella V-Test Coris BioConcept test Batch Number of kit: 2149H1006 Batch Number of sticks: 1W15G1013D Batch Number of extraction: - Comparator(s) Method(s): EIA Legionella Urinary Antigen test Trinity Biotech Batch Number of kit: - Brief description of that reference method used: The Bartels EIA assay (Bartels EIA Legionella Urinary Antigen. Bartels Inc., A Trinity Biotech Company, Wicklow, Ireland) is a direct sandwich test that uses polyclonal rabbit antibodies which react with L. pneumophila serogroup 1 antigen as the capture and detection antibody. Results were read using a microplate reader, although a visual interpretation was possible. Samples were considered positive when ratios were higher than 4 (the absorbance value was 4 times the absorbance value of the negative control). The test was performed following the manufacturer s instructions. Study Objective: The aim of this retrospective study was to evaluate the sensitivity and specificity of Legionella V-Test Coris BioConcept test in the diagnosis of Legionella pneumonia using non concentrated urine (), comparing the results to EIA Legionella Urinary Antigen test Trinity Biotech using concentrated urine (CU). Sample type tested and collection method: The test was performed using. The collected samples were stored at -80ºC.

4 Study Population and samples collected (number of samplings to test): Group 1.- Urine samples from 57 patients with pneumonia due to L. pneumophila will be studied. Legionnaires disease was diagnosed by isolation of L. pneumophila, by seroconversion, and/or by detection of soluble antigen in concentrated urine samples. Group 2.- Urine samples from 43 patients with confirmed pneumonia of other etiologies and patients with no clinical or radiological signs of pneumonia: healthy people, patients with bacteremia from a nonrespiratory focus, and patients with urinary tract infections. Methods employed: - EIA Legionella Urinary Antigen test Trinity Biotech - Legionella V-Test Coris BioConcept test - Amicon Ultra-4. Millipore Corporation. Bedford, MA Recommendations of the both manufacturers have been followed. Trials findings summary: Clinical Status POS NEG total Coris Test POS Non Concentrated Urine NEG total Sensitivity: 80.7% (TP/ (TP+FN)) Specificity: 100% (TN/ (TN+FP)) Reliability: 89% (TN+TP)/Total) Positive Predictive Value: Not applicable % (TP/(TP+FP)) Negative Predictive Value: Not applicable % (TN/ (TN+ FN)) The 11 urine samples with discordant result between CU EIA Bartels and ICT Coris results were retested by ICT Coris using CU. The antigen present in the 11 samples was concentrated 25 times by selective ultrafiltration. After concentration the ICT Coris was positive in 9 of the 11 samples (81.8%). Therefore, we could consider that the overall ICT Coris sensitivity was 96.5% (46+9/57). Interestingly, the 2 negative CU ICT Coris samples were also negative by the ICT Binax (Table 3). On the other hand, from the 11 urine samples with discordant result in 10 cases urine was available to test by the EIA Bartels using. The EIA Bartels was positive in 7 cases and negative in 3, being in the 3 cases the ICT Binax in and CU also negative (Table 3). A summary of the Study results are presented in the following figure.

5 Positive EIA Bartels CU n= 57 Positive ICT CORIS n= 46 Negative ICT CORIS n= 11 Positive ICT CORIS CU n= 9 Negative ICT CORIS CU n= 2 Negative ICT Binax n= 2 Positive EIA Bartels n= 7 Negative EIA Bartels n= 3 Urine sample not available n= 1 Negative ICT Binax & CU n= 3

6 Conclusion: 1. ICT Coris is a technique simple to perform, with good sensitivity and specificity, and the results are obtained in 15 minutes or less. 2. It s a good screening test to detect L. pneumophila antigen from urine samples. 3. Our results show that ICT Coris is comparable in sensitivity and specificity with the EIA Bartels. However, ITC Coris sensitivity is slightly lower than EIA Bartels in both non concentrated urine and concentrated urine samples. 4. The ICT Coris sensitivity increases using concentrated urine samples by selective ultrafiltration. 5. The technique is especially useful for small hospital laboratories without appropriate equipment and/or a small number of samples to perform the EIA Bartels test.

7 Table 1. Results for Each Specimen from patients Group 1 The status of samples is defined by the reference method used and should be notified as: N: Negative, P: Positive, TN: True Negative, TP: True Positive, FN: False Negative, FP: False Positive SN Sample Number Comparative technique Coris Test Results Positive Positive TP Positive Low Positive TP Positive Low Positive TP Positive Low Positive TP Positive Low Positive TP Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Negative FN Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP A6 Positive Positive TP A5 Positive Positive TP A2 Positive Positive TP Positive Positive TP

8 SN Sample Number Comparative technique Coris Test Results Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP Positive Positive TP

9 Table 2. Results for Each Specimen from patients Group 2 SN Sample Number Comparative technique Coris Test Results 58 8 Negative Negative TN Negative Negative TN Negative Negative TN 61 9 Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN A3 Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN Negative Negative TN

10 Table 2. Discordant Results for Each Specimen from patients Group 1 SN Sample Number Comparative technique Coris Test Results Coris Test CU EIA Bartels Positive Negative FN Positive Positive Positive Negative FN Positive Positive Positive Negative FN Low Positive Positive Positive Negative FN Low Positive Positive - Additional results: ICT Binax & CU Positive Negative FN Negative Negative Negative Positive Negative FN Negative Negative Negative Positive Negative FN Positive Positive Positive Negative FN Positive Negative Negative () Positive Negative FN Positive Positive Negative () Positive Negative FN Low Positive N.A. Negative () Positive Negative FN Positive Positive -

JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.

JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved. JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p. 2718 2722 Vol. 36, No. 9 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Comparison of the Binax Legionella

More information

Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults

Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults Respiratory Medicine (2006) 100, 884 891 Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults Felipe Andreo a,, José Domínguez b, Juan Ruiz a, Silvia

More information

Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients

Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients Respiratory Medicine (2010) 104, 397e403 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Utility of pneumococcal urinary antigen detection in diagnosing exacerbations

More information

Received 3 August 2005/Returned for modification 13 September 2005/Accepted 13 January 2006

Received 3 August 2005/Returned for modification 13 September 2005/Accepted 13 January 2006 CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2006, p. 361 364 Vol. 13, No. 3 1556-6811/06/$08.00 0 doi:10.1128/cvi.13.3.361 364.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Evaluation

More information

Evaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella

Evaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella JCM Accepts, published online ahead of print on 6 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00397-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital

Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital 101 Research article Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital Abstract BN Dissanayake 1,, DE Jayawardena 2, CG Senevirathna 1, TM Gamage 1 Sri Lankan Journal

More information

Sporadic and epidemic community legionellosis: two faces of the same illness

Sporadic and epidemic community legionellosis: two faces of the same illness Eur Respir J 2007; 29: 138 142 DOI: 10.1183/09031936.00077206 CopyrightßERS Journals Ltd 2007 Sporadic and epidemic community legionellosis: two faces of the same illness N. Sopena*, L. Force #, M.L. Pedro-Botet*,

More information

Annual Epidemiological Report

Annual Epidemiological Report July 2018 Annual Epidemiological Report 1 Legionellosis in Ireland, 2017 Key Facts There were 25 cases of Legionnaires disease notified in Ireland in 2017 The rate per million population increased from

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory

More information

IMMUVIEW S. PNEUMONIAE AND L. PNEUMOPHILA URINARY ANTIGEN TEST. SSI Diagnostica ENGLISH

IMMUVIEW S. PNEUMONIAE AND L. PNEUMOPHILA URINARY ANTIGEN TEST. SSI Diagnostica ENGLISH IMMUVIEW S. PNEUMONIAE AND L. PNEUMOPHILA URINARY ANTIGEN TEST Combined lateral flow test for qualitative detection of S. pneumoniae and L. pneumophila in urine and cerebrospinal fluid. ENGLISH SSI Diagnostica

More information

Trends in Human Immunodeficiency Virus Infection among Drug Users in a Detoxification Unit

Trends in Human Immunodeficiency Virus Infection among Drug Users in a Detoxification Unit SUPPLEMENT ARTICLE Trends in Human Immunodeficiency Virus Infection among Drug Users in a Detoxification Unit Roberto Muga, Arantza Sanvisens, José Manuel Egea, Jordi Tor, and Celestino Rey-Joly Department

More information

Probability Revision. MED INF 406 Assignment 5. Golkonda, Jyothi 11/4/2012

Probability Revision. MED INF 406 Assignment 5. Golkonda, Jyothi 11/4/2012 Probability Revision MED INF 406 Assignment 5 Golkonda, Jyothi 11/4/2012 Problem Statement Assume that the incidence for Lyme disease in the state of Connecticut is 78 cases per 100,000. A diagnostic test

More information

Biochemical investigations in clinical medicine

Biochemical investigations in clinical medicine Biochemical investigations in clinical medicine Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy Introduction What it is? Clinical

More information

Current and Emerging Legionella Diagnostics

Current and Emerging Legionella Diagnostics Current and Emerging Legionella Diagnostics Nicole Wolter Centre for Respiratory Diseases and Meningitis (CRDM) National Institute for Communicable Diseases nicolew@nicd.ac.za 7 th FIDSSA Conference, Cape

More information

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults Eur Respir J 2003; 21: 209 214 DOI: 10.1183/09031936.03.00058802 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Rapid urinary antigen test

More information

International Journal of Basic, Applied and Innovative Research

International Journal of Basic, Applied and Innovative Research International Journal of Basic, Applied and Innovative Research ISSN: 2315-5388 RESEARCH PAPER IJBAIR, 2017, 6(3): 72-80 www.arpjournals.com; www.antrescentpub.com DETECTION OF LEGIONELLA ANTIGEN IN URINE

More information

LEGIONELLA PNEUMOPHILA IFA SLIDE

LEGIONELLA PNEUMOPHILA IFA SLIDE 1 LEGIONELLA PNEUMOPHILA IFA SLIDE SLEPN: Slides kit for the diagnosis of Legionella pneumophila antibodies in human serum by indirect immunofluorescent assay (IFA). INTRODUCTION: More than 30 species

More information

IMMUVIEW. S. pneumoniae and L. pneumophila Urinary Antigen Test ENGLISH

IMMUVIEW. S. pneumoniae and L. pneumophila Urinary Antigen Test ENGLISH IMMUVIEW S. pneumoniae and L. pneumophila Urinary Antigen Test ENGLISH Combined lateral flow test for qualitative detection of S. pneumoniae and L. pneumophila antigens in urine and S. pneumoniae in cerebrospinal

More information

IMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST. SSI Diagnostica

IMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST. SSI Diagnostica IMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST SSI Diagnostica 2 IMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST For in vitro diagnostic use Intended use The ImmuView and

More information

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Bioelisa HCV 4.0 Number: PQDx Abstract

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Bioelisa HCV 4.0 Number: PQDx Abstract WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: Bioelisa HCV 4.0 Number: PQDx 0165-060-00 Abstract Bioelisa HCV 4.0 with product codes 3000-1115 and 3000-1116, manufactured by Biokit

More information

Sensitivity of three serum antibody tests in a large outbreak of Legionnaires disease in the Netherlands

Sensitivity of three serum antibody tests in a large outbreak of Legionnaires disease in the Netherlands Journal of Medical Microbiology (2006), 55, 561 566 DOI 10.1099/jmm.0.46369-0 Sensitivity of three serum antibody tests in a large outbreak of Legionnaires disease in the Netherlands Ed P. F. Yzerman,

More information

IMMUVIEW S. pneumoniae and L. pneumophila UrInary antigen test

IMMUVIEW S. pneumoniae and L. pneumophila UrInary antigen test IMMUVIEW S. pneumoniae and L. pneumophila UrInary antigen test EngLISh SSI Diagnostica Para otras lenguas Para outras linguas Für andere Sprachen Pour d autres langues Per le altre lingue For andre språk

More information

PCR Is Not Always the Answer

PCR Is Not Always the Answer PCR Is Not Always the Answer Nicholas M. Moore, PhD(c), MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted

More information

Citation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n.

Citation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n. University of Groningen Progress in diagnostics and prevention of Legionnaires' disease IJzerman, Eddy Peter Frans IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if

More information

Legionellosis. Legionnaires Disease Pontiac fever Rare non pneumonic infections 10/04/2015. Nonmotile replicative phase inside amoebae

Legionellosis. Legionnaires Disease Pontiac fever Rare non pneumonic infections 10/04/2015. Nonmotile replicative phase inside amoebae Legionellosis Legionnaires Disease Pontiac fever Rare non pneumonic infections Planktonic flagellated virulent transmissive Nonmotile replicative phase inside amoebae 1 Biofilm in plumbing system 2 Clin

More information

HBsAg CONFIRMATORY TEST

HBsAg CONFIRMATORY TEST HBsAg CONFIRMATORY TEST For the confirmation of positive samples with UMELISA HBsAg PLUS CLINICAL INTEREST After the discovery of Hepatitis B surface Antigen (HBsAg)(1), increasingly sensitive and specific

More information

IMMUVIEW S. PNEUMONIAE ANTIGEN TEST. Lateral flow test for qualitative detection of S. pneumoniae in urine and cerebrospinal fluid.

IMMUVIEW S. PNEUMONIAE ANTIGEN TEST. Lateral flow test for qualitative detection of S. pneumoniae in urine and cerebrospinal fluid. IMMUVIEW S. PNEUMONIAE ANTIGEN TEST Lateral flow test for qualitative detection of S. pneumoniae in urine and cerebrospinal fluid. 2 IMMUVIEW S. PNEUMONIAE ANTIGEN TEST For in vitro diagnostic use Application

More information

Citation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n.

Citation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n. University of Groningen Progress in diagnostics and prevention of Legionnaires' disease IJzerman, Eddy Peter Frans IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Uni-Gold HIV Number: PQDx 0149-052-00 Abstract Uni-Gold HIV with product codes 1206502, 1206502N, 1206502E, 1206502N-100 manufactured

More information

Citation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n.

Citation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n. University of Groningen Progress in diagnostics and prevention of Legionnaires' disease IJzerman, Eddy Peter Frans IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if

More information

Table Of Content. European Prevention Initiative for Dermatological Malignancies... 2 Summary... 3 Coordinator, Leader contact and partners...

Table Of Content. European Prevention Initiative for Dermatological Malignancies... 2 Summary... 3 Coordinator, Leader contact and partners... Table Of Content European Prevention Initiative for Dermatological Malignancies... 2 Summary... 3 Coordinator, Leader contact and partners... 4 Sir Paul Boffa Hospital - SPBH... 4 Aristotle University

More information

Next Generation Rapid Diagnostics

Next Generation Rapid Diagnostics Next Generation Rapid Diagnostics INTERNATIONAL PRODUCT CATALOG Quidel is a leading manufacturer of diagnostic healthcare solutions serving to enhance the health and well-being of people around the globe

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Uni-Gold HIV Number: PQDx Abstract WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Uni-Gold HIV Number: PQDx 0149-052-00 Abstract Uni-Gold HIV with product codes 1206502, 1206502N, 1206502E, 1206502N-100 manufactured

More information

Evaluating reagents for serological diagnosis of Leptospirosis EPINET 1 Workshop (Guam, December 2001)

Evaluating reagents for serological diagnosis of Leptospirosis EPINET 1 Workshop (Guam, December 2001) Evaluating reagents for serological diagnosis of Leptospirosis EPINET 1 Workshop (Guam, December 2001) Alain Berlioz-Arthaud, New Caledonia Pasteur Institute, B.P. 61, 98845 Noumea, NC aberlioz@pasteur.nc

More information

Comparative evaluation of Immunochromatographic Assay for screening Hepatitis C among blood donors in a rural teaching hospital, Sangareddy

Comparative evaluation of Immunochromatographic Assay for screening Hepatitis C among blood donors in a rural teaching hospital, Sangareddy Original Research Article Comparative evaluation of Immunochromatographic Assay for screening Hepatitis C among blood donors in a rural teaching hospital, Sangareddy Nagababu Pyadala 1*, Prudhvi Chand

More information

Chapter 10. Screening for Disease

Chapter 10. Screening for Disease Chapter 10 Screening for Disease 1 Terminology Reliability agreement of ratings/diagnoses, reproducibility Inter-rater reliability agreement between two independent raters Intra-rater reliability agreement

More information

Influence of Social Media on an Acute Respiratory Outbreak at a High Profile Party Venue Los Angeles, February 2011

Influence of Social Media on an Acute Respiratory Outbreak at a High Profile Party Venue Los Angeles, February 2011 Influence of Social Media on an Acute Respiratory Outbreak at a High Profile Party Venue Los Angeles, February 2011 Dawn Terashita, MD, MPH Acute Communicable Disease Control Los Angeles County Department

More information

A multicenter evaluation of the Biotest legionella

A multicenter evaluation of the Biotest legionella ORIGINAL ARTICLE A multicenter evaluation of the Biotest legionella urinary antigen EIA Timothy Harrison', Ssren Uldum', Stella Alexiou-Daniel3, Jette Bangsbo~g~, Sverker Be~nander~, Vladimir Drarar 6,

More information

Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy

Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy MAJOR ARTICLE Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy Analía Mykietiuk, 1 Jordi Carratalà, 1 Núria Fernández-Sabé,

More information

Submitted: February 15, 2013 Posted: March 16, 2013

Submitted: February 15, 2013 Posted: March 16, 2013 1 Submitted: February 15, 2013 Posted: March 16, 2013 TITLE: The results of the validation process of a Modified SGA (Subjective Global Assessment) Nutrition Assessment and Risk Level Tool designed by

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Department of Microbiology Princess Alexandra Hospital Hamstel Road Harlow CM20 1QX Contact: D Orriss Tel: +44 01279 827138 E-Mail: Debbie.Orriss@pah.nhs.uk

More information

Impact of pre-hospital antibiotic use on community-acquired pneumonia

Impact of pre-hospital antibiotic use on community-acquired pneumonia ORIGINAL ARTICLE INFECTIOUS DISEASE Impact of antibiotic use on community-acquired pneumonia A. F. Simonetti 1, D. Viasus 1,2, C. Garcia-Vidal 1,2, S. Grillo 1, L. Molero 1, J. Dorca 3,4 and J. Carratala

More information

Understanding diagnostic tests. P.J. Devereaux, MD, PhD McMaster University

Understanding diagnostic tests. P.J. Devereaux, MD, PhD McMaster University Understanding diagnostic tests P.J. Devereaux, MD, PhD McMaster University Goals Understand sensitivity and specificity inform why they are in general problematic Discuss likelihood ratios Inform pretest

More information

MAESTRO TRIAL FINAL RESULTS. Gisela L.G. Menezes, MD, PhD

MAESTRO TRIAL FINAL RESULTS. Gisela L.G. Menezes, MD, PhD MAESTRO TRIAL FINAL RESULTS Gisela L.G. Menezes, MD, PhD MAESTRO Angiogenesis Metastasis How does OA work? Malignant Benign How does OA work? D O How does OA work? Optoacoustic Imaging Fibroadenoma IDC

More information

4.6. How to test - testing strategy HCV. Decision-making tables PICO 4

4.6. How to test - testing strategy HCV. Decision-making tables PICO 4 4.6. How to test - testing strategy HCV Decision-making tables PICO 4 Testing strategy to ascertain exposure to HCV: Among persons identified for hepatitis C testing, what is the best testing strategy

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Bioelisa HIV 1+2 Ag/Ab Number: PQDx

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Bioelisa HIV 1+2 Ag/Ab Number: PQDx WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Bioelisa HIV 1+2 Ag/Ab Number: PQDx 0183-060-00 Abstract Bioelisa HIV 1+2 Ag/Ab with product codes 3000-1172 and 300-1173,

More information

Sensitivity, Specificity, and Relatives

Sensitivity, Specificity, and Relatives Sensitivity, Specificity, and Relatives Brani Vidakovic ISyE 6421/ BMED 6700 Vidakovic, B. Se Sp and Relatives January 17, 2017 1 / 26 Overview Today: Vidakovic, B. Se Sp and Relatives January 17, 2017

More information

Mouse HBsAg(Hepatitis B Virus Surface Antigen) ELISA Kit

Mouse HBsAg(Hepatitis B Virus Surface Antigen) ELISA Kit Mouse HBsAg(Hepatitis B Virus Surface Antigen) ELISA Kit Catalogue No.: EM0002 Size: 96T Reactivity: Mouse Application: This immunoassay kit allows for the qualitative determination of HBsAg in Mouse serum

More information

Data that can be classified as belonging to a distinct number of categories >>result in categorical responses. And this includes:

Data that can be classified as belonging to a distinct number of categories >>result in categorical responses. And this includes: This sheets starts from slide #83 to the end ofslide #4. If u read this sheet you don`t have to return back to the slides at all, they are included here. Categorical Data (Qualitative data): Data that

More information

Epidemiology of Legionnaires Disease in Europe Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016

Epidemiology of Legionnaires Disease in Europe Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016 Epidemiology of Legionnaires Disease in Europe 2015 Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016 ELDSNet annual data set Methods ECDC coordination Collection of disaggregate

More information

Identification of a cytokine expression pattern specific for the first month of HIV infection

Identification of a cytokine expression pattern specific for the first month of HIV infection Abstract no. TUPEA023 Identification of a cytokine expression pattern specific for the first month of HIV infection Pastor L (1)(2)(3), Parker E (4), Carrillo J (1)(2), Urrea V (1), Fuente-Soro L (2)(5),

More information

DAILY PROGRAMME HIGHLIGHTS

DAILY PROGRAMME HIGHLIGHTS DAILY PROGRAMME HIGHLIGHTS Please visit the programme page on the conference website for a full list of conference sessions and satellite meetings taking place at the CCIB or offsite, as well as a daily

More information

SAMPLE. Collecting a faeces specimen

SAMPLE. Collecting a faeces specimen 7. Perform steps 10 16 of the common steps (see pp. 39 43). Evidence base: PHE (2014a) To ensure that: the patient is safe and comfortable. the specimen has been correctly collected and documented in the

More information

Institut Pasteur de Nouvelle Calédonie 12 / 12 / 02

Institut Pasteur de Nouvelle Calédonie 12 / 12 / 02 Evaluation of reagents for the serological diagnosis of Dengue EPINET II Workshop (Noumea, March, 2002) Alain BERLIOZ-ARTHAUD, New Caledonia Pasteur Institute, B.P. 61, 98845 Noumea, NC aberlioz@pasteur.nc

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Derriford Hospital Derriford Road Plymouth PL6 8DH Contact: John Hooper Tel: +44 (0) 1752 792369 E-Mail: johnhooper@nhs.net Website: www.plymouthhospitals.nhs.uk/pathologywelcome

More information

The NEPHROCHECK Test System Training Program. The NEPHROCHECK Training Program US: Astute Medical, Inc PN Rev D 2014/09/16

The NEPHROCHECK Test System Training Program. The NEPHROCHECK Training Program US: Astute Medical, Inc PN Rev D 2014/09/16 The NEPHROCHECK Test System Training Program The NEPHROCHECK Training Program US: Astute Medical, Inc. 2014 PN 700001 Rev D 2014/09/16 Learning Objectives At the conclusion of this training, participants

More information

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 25, 2018 0800 EDT NH-HAN 20180825 Cluster of Legionella pneumophila Pneumonia (Legionnaire

More information

MICROBIOLOGICAL TESTING IN PICU

MICROBIOLOGICAL TESTING IN PICU MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes

More information

Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc)

Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) Date: 6 January 2012 Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) WHO Collaborating Centre for HIV/AIDS Diagnostic and Laboratory Support Department of Clinical Sciences

More information

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma Test Name *Minimum Collection Tubes Sample Stability ABO/Rh Blood Typing 50 µl cells EDTA whole blood (lavender-top) Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Murex HIV Ag/Ab Combination Number: PQDx

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Murex HIV Ag/Ab Combination Number: PQDx WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Murex HIV Ag/Ab Combination Number: PQDx 0144-043-00 Abstract Murex HIV Ag/Ab Combination with product codes 7G79-09 (GE41,

More information

HIV-1 ICx/CRx Kit Reagents for Immune Dissociation and Reactivity Confirmation

HIV-1 ICx/CRx Kit Reagents for Immune Dissociation and Reactivity Confirmation INTENDED USE The RETRO-TEK HIV-1 IC x/cr x Kit is supplied for research purposes only. It is not intended for use in the diagnosis or prognosis of disease or for screening and may not be used as a confirmatory

More information

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Alere Determine HIV-1/2 Number: PQDx Abstract

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Alere Determine HIV-1/2 Number: PQDx Abstract WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: Alere Determine HIV-1/2 Number: PQDx 0033-013-00 Abstract The Alere Determine HIV-1/2 with product codes 1 7D2342, 7D2343 and 7D2243

More information

Optimizing Immunotherapy New Approaches, Biomarkers, Sequences and Combinations Immunotherapy in the clinic Melanoma

Optimizing Immunotherapy New Approaches, Biomarkers, Sequences and Combinations Immunotherapy in the clinic Melanoma Optimizing Immunotherapy New Approaches, Biomarkers, Sequences and Combinations Immunotherapy in the clinic Melanoma Dr. J.L.Manzano S. Oncología Médica H. Germans Trias i Pujol, ICO-Badalona PRBB Auditorium,

More information

Biomedical Engineering for Global Health

Biomedical Engineering for Global Health Four Questions Biomedical Engineering for Global Health Lecture Eleven What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems?

More information

Annals of the American Thoracic Society

Annals of the American Thoracic Society Annals of the American Thoracic Society Sensitivity, specificity and positivity predictors of the pneumococcal urinary antigen test in community acquired pneumonia Journal: Annals of the American Thoracic

More information

Assessment of diabetic retinopathy risk with random forests

Assessment of diabetic retinopathy risk with random forests Assessment of diabetic retinopathy risk with random forests Silvia Sanromà, Antonio Moreno, Aida Valls, Pedro Romero2, Sofia de la Riva2 and Ramon Sagarra2* Departament d Enginyeria Informàtica i Matemàtiques

More information

IMTEC-ANA-LIA MAXX. Design Verification

IMTEC-ANA-LIA MAXX. Design Verification Design Verification IMTEC-ANA-LIA MAXX CONTENTS 1 Intended Use... 2 2 Diagnostic Sensitivity and Specificity... 2 3 Interferences... 4 4 Imprecision... 6 4.1 Within-Run Imprecision... 6 4.2 Between-Run

More information

H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set

H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set Catalog Number : SEK002 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized

More information

Guideline on the management of Legionella cases, incidents, outbreaks and clusters in the community Quick Reference Guide

Guideline on the management of Legionella cases, incidents, outbreaks and clusters in the community Quick Reference Guide 2 2014 Edition Guideline on the management of Legionella cases, incidents, outbreaks and clusters in the community Quick Reference Guide Health Protection Network Scottish Guidance November 2014 Initial

More information

PCR Is Not Always the Answer

PCR Is Not Always the Answer PCR Is Not Always the Answer Nicholas M. Moore, PhD, MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted research:

More information

Murex Chlamydia Verification Kit

Murex Chlamydia Verification Kit 1F83-01 E C06DK05GB Murex Chlamydia Verification Kit DK05 For the confirmatory testing of clinical samples reactive in Murex Chlamydia (1F82-01) Note Changes Highlighted 2005 Abbott / Printed in the UK

More information

Bioengineering and World Health. Lecture Twelve

Bioengineering and World Health. Lecture Twelve Bioengineering and World Health Lecture Twelve Four Questions What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How

More information

L egionella pneumophila (LP) is, in most studies,

L egionella pneumophila (LP) is, in most studies, Comparative Study of the Clinical Presentation of Legionella Pneumonia and Other Community-Acquired Pneumonias* Nieves Sapena, MD; Miquel Sabria-Leal, MD, PhD; Maria Lluisa Pedro-Botet, MD, PhD; Eduardo

More information

Human Legionella ELISA Kit

Human Legionella ELISA Kit Human Legionella ELISA Kit Cat.No:DEIA1721 Lot. No. (See product label) PRODUCT INFOMATION Storage Pkg#Size Intended use Principle Of The Test Reagents And Materials Provided 1. Store the unopened kit

More information

Evidence-based guidelines for diagnosis of common bile duct stones Vanja Giljaca University Hospital Center Rijeka Department of Gastroenterology

Evidence-based guidelines for diagnosis of common bile duct stones Vanja Giljaca University Hospital Center Rijeka Department of Gastroenterology Evidencebased guidelines for diagnosis of common bile duct stones Vanja Giljaca University Hospital Center Rijeka Department of Gastroenterology Trusted evidence. Informed decisions. Better health. Outline

More information

ReQuest EB VCA IgM L

ReQuest EB VCA IgM L 01-480 96-Test Set For in Vitro Diagnostic Use Only Intended Use: For the qualitative detection of human IgM antibodies to Epstein-Barr (EB) viral capsid antigen (VCA) in human serum by enzyme immunoassay,

More information

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay

More information

Preventing Legionella Transmission An Environmental Health View

Preventing Legionella Transmission An Environmental Health View Preventing Legionella Transmission An Environmental Health View April 25, 2013 Erin Reinsborough Environmental Health Specialist Mission Statement Together with the Halton community, the Health Department

More information

100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010

100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010 Currently Approved CBER Device Premarket Applications (PMAs) As of Nov 10, 2014 Sorted by Applicant Name BP090080-0 BP060002-0 BP120037-0 BP090022-0 BP090032-0 BP040046-0 BP100064-0 BP140120-0 Abbott Laboratories

More information

D-FRUCTOSE and D-GLUCOSE

D-FRUCTOSE and D-GLUCOSE www.megazyme.com DFRUCTOSE and DGLUCOSE (Liquid Stable Format) ASSAY PROCEDURE KFRGLQR 02/17 (1100 AutoAnalyser Assays of each per Kit) or (1100 Microplate Assays of each per Kit) Megazyme 2017 INTRODUCTION:

More information

TSH (Human) CLIA Kit. Catalog Number KA assays Version: 01. Intended for research use only.

TSH (Human) CLIA Kit. Catalog Number KA assays Version: 01. Intended for research use only. TSH (Human) CLIA Kit Catalog Number KA2795 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...

More information

Value of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline

Value of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline Value of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline Presenter: Elisabetta Fenu, Health Economics Lead Co-author: Chris Kiff National Clinical Guideline

More information

EPIDEMIOLOGY SURVEILLANCE REPORT Northeast Region. Namitha Reddy Regional Coordinator North/Central West Region

EPIDEMIOLOGY SURVEILLANCE REPORT Northeast Region. Namitha Reddy Regional Coordinator North/Central West Region EPIDEMIOLOGY SURVEILLANCE REPORT Northeast Region Namitha Reddy Regional Coordinator North/Central West Region 1 This report is for use by Public Health Officials only and not for public distribution.

More information

Diagnostic tests, Laboratory tests

Diagnostic tests, Laboratory tests Diagnostic tests, Laboratory tests I. Introduction II. III. IV. Informational values of a test Consequences of the prevalence rate Sequential use of 2 tests V. Selection of a threshold: the ROC curve VI.

More information

Figure 1: Design and outcomes of an independent blind study with gold/reference standard comparison. Adapted from DCEB (1981b)

Figure 1: Design and outcomes of an independent blind study with gold/reference standard comparison. Adapted from DCEB (1981b) Page 1 of 1 Diagnostic test investigated indicates the patient has the Diagnostic test investigated indicates the patient does not have the Gold/reference standard indicates the patient has the True positive

More information

Critical Appraisal. Einas Al-Eisa, MSc, PhD King Saud University

Critical Appraisal. Einas Al-Eisa, MSc, PhD King Saud University Critical Appraisal Einas Al-Eisa, MSc, PhD King Saud University Critical Appraisal = assessment of evidence by systematically reviewing its: Relevance Validity Applicability of its results to specific

More information

With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV 1+2 Ag/Ab from 10 to 12 months.

With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV 1+2 Ag/Ab from 10 to 12 months. 1 NEWS BK NEWS # 377 /MKT DATE : 18-01-2016 TITLE : SHELF-LIFE EXTENSION OF bioelisa HIV 1+2 Ag/Ab With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV

More information

Health Studies 315: Handouts. Health Studies 315: Handouts

Health Studies 315: Handouts. Health Studies 315: Handouts Health Studies 315: Handouts Health Studies 315: Handouts l Lecture Notes l Last YearÍs Exam l Article: Wagner, JM, McKinney, P, Carpenter, JL. Does this patient have appendicitis? JAMA 276(19):1589-1594

More information

2006 HIV Diagnostics Survey

2006 HIV Diagnostics Survey Public Health Laboratory Issues in Brief: 2006 HIV Diagnostics Survey Association of Public Health Laboratories November 2007 Background Nearly 20 years ago, the Association of Public Health Laboratories

More information

RELIABILITY OF OPERATORS DURING THE VISUAL INSPECTION OF PRODUCED PARENTERAL DRUGS

RELIABILITY OF OPERATORS DURING THE VISUAL INSPECTION OF PRODUCED PARENTERAL DRUGS RELIABILITY OF OPERATORS DURING THE VISUAL INSPECTION OF PRODUCED PARENTERAL DRUGS F. Sadeghipour, A. Bugmann, V. Herrera, P. Bonnabry Geneva, 22 March 2006 11th Congress of the European Association of

More information

ELEGANCE Chlamydia pneumoniae IgG ELISA KIT

ELEGANCE Chlamydia pneumoniae IgG ELISA KIT INTENDED USE The ELEGANCE Chlamydia pneumoniae IgG ELISA has been designed for the in vitro diagnostic measurement of anti- Chlamydia pneumoniae IgG in the screening of human serum. PRINCIPLES OF THE ELEGANCE

More information

Evaluation of the LIAISON Treponema Assay, a Chemiluminescent Immunoassay ACCEPTED

Evaluation of the LIAISON Treponema Assay, a Chemiluminescent Immunoassay ACCEPTED CVI Accepts, published online ahead of print on 25 April 2007 Clin. Vaccine Immunol. doi:10.1128/cvi.00068-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

BIOE 301. Lecture Eleven

BIOE 301. Lecture Eleven BIOE 301 Lecture Eleven Four Questions What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How are health care technologies

More information

Legionnaire s disease is a febrile illness with pneumonia. The Radiologic Manifestations of Legionnaire s Disease*

Legionnaire s disease is a febrile illness with pneumonia. The Radiologic Manifestations of Legionnaire s Disease* The Radiologic Manifestations of Legionnaire s Disease* Michael J. Tan, MD; James S. Tan, MD, FCCP; Robert H. Hamor, MD; Thomas M. File, Jr., MD, FCCP; Robert F. Breiman, MD; and the Ohio Community-Based

More information

BIOE 301. The Burden of Cancer: U.S. Four Questions. Lecture Eleven. Three Case Studies. Outline. U.S. Cancer Incidence & Mortality 2009

BIOE 301. The Burden of Cancer: U.S. Four Questions. Lecture Eleven. Three Case Studies. Outline. U.S. Cancer Incidence & Mortality 2009 Four Questions BIOE 31 Lecture Eleven What are the major health problems worldwide? Who pays to solve problems in health care? How can technology solve health care problems? How are health care technologies

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Alere HIV/Syphilis Duo Number: PQDx

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Alere HIV/Syphilis Duo Number: PQDx WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Alere HIV/Syphilis Duo Number: PQDx 0179-012-00 Abstract Alere HIV/Syphilis Duo with product codes 06FK30 and 06FK35, manufactured

More information

MAJOR ARTICLE. Atypical Pneumonia in Thailand CID 2007:45 (15 December) e147

MAJOR ARTICLE. Atypical Pneumonia in Thailand CID 2007:45 (15 December) e147 MAJOR ARTICLE Epidemiology of Severe Pneumonia Caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-Year, Population- Based Surveillance for Severe Pneumonia in Thailand

More information

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016 Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of

More information

Chlamydia MIF IgG. Performance Characteristics. Product Code IF1250G Rev. J. Not for Distribution in the United States

Chlamydia MIF IgG. Performance Characteristics. Product Code IF1250G Rev. J. Not for Distribution in the United States Product Code IF1250G Rev. J Performance Characteristics Not for Distribution in the United States EXPECTED VALUES Community Acquired Pneumonia Population Two outside investigators assessed the Focus Chlamydia

More information